[C-reactive protein and coronary heart disease: quo vadis?].
März
Winfried
W
Synlab Medizinisches Versorgungszentrum für Labordiagnostik Heidelberg. winfried.maerz@synlab.de
Grammer
Tanja B
TB
D000483:Alleles; D001057:Apolipoproteins E / Q000235:genetics; D002097:C-Reactive Protein / Q000235:genetics / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000097:blood; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D011110:Polymorphism, Genetic / Q000235:genetics; D011743:Pyrimidines / Q000627:therapeutic use; D012307:Risk Factors; D000068718:Rosuvastatin Calcium; D020521:Stroke / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000517:prevention & control; D013449:Sulfonamides / Q000627:therapeutic use
D001057:Apolipoproteins E; D008078:Cholesterol, LDL; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D002097:C-Reactive Protein